Differences in the absorption, metabolism and biliary excretion of a diastereomeric pair of α v β 3 - antagonists in rat: limited role of P-glycoprotein

References

• BARR, W. H. and RIEGELMAN, S., 1970, Intestinal drug absorption and metabolism. I. Comparison of methods and models to studying physiological factors of in vitro and in vivo intestinal absorption. Journal of Pharmaceutical Sciences, 59, 154–163.
   PubMed Web of Science ®Google Scholar
• BENET, L. Z. and GALEAZZI, R. L., 1979, Noncompartmental determination of the steady-state volume of distribution. Journal of Pharmaceutical Sciences, 68, 1071–1074.
   PubMed Web of Science ®Google Scholar
• CHIOU, W. L., CHUNG, S. M. and Wu, T. C., 2000, Apparent lack of effect of P-glycoprotein on the gastrointestinal absorption of a substrate, tacrolimus, in normal mice. Pharmaceutical Research, 17, 205–208.
   PubMed Web of Science ®Google Scholar
• DAVIES, N. M., 1998, Clinical pharmacokinetics of ibuprofen. The first 30 years. Clinical Pharmacokinetics, 34, 101–154.
   PubMed Web of Science ®Google Scholar
• DESRAYAUD, S., DE LANGE, E. C. M., BRUELISAUER, A., DE BOER, A. G. and BREIMER, D. D., 1998, Effect of the mdrla P-glycoprotein gene disruption on the tissue distribution of SDZ PSC 833, a multidrug resistance-reversing agent, in mice. Journal of Pharmacology and Experimental Therapeutics, 285, 438–443.
   Google Scholar
• FLENS, M. J., ZAMAN, G. J. R., VAN DER VALK, P., IZQUIERDO, M. A., SCHROEIJERS, A. B., SCHEFFER, G. L., VAN DER GROEP, P., DE HASS, M., MEIJER, C. J. L. M. and SCHEPER, R. J., 1996, Tissue distribution of the multidrug resistance protein. American Journal of Pathology, 148, 1237–1247.
   Google Scholar
• FORD, J. M. and HAIT, W. H., 1990, Pharmacology of drugs that alter multidrug resistance in cancer. Pharmacological Reviews, 42, 155–199.
   PubMed Web of Science ®Google Scholar
• GEKELER, V., SANDERS, K. H., ULRICH, W. R. and BECK, J., 1995, The leukotriene LTD4 receptor antagonist MK571 specifically modulates MRP associated multidrug resistance. Biochemical and Biophysical Research Communications, 208, 345–353.
   PubMed Web of Science ®Google Scholar
• HARTMAN, G. D. and DUGGAN, M. E., 2000, Alpha (v) beta (3) integrin antagonists as inhibitors of bone resorption. Expert Opinion on Investigational Drugs, 9, 1281–1291.
   PubMed Web of Science ®Google Scholar
• HIROHASHI, T., SUZUKI, H., CHU, X. Y., TAMAI, I., TSUJI, A. and SUGIYAMA, Y., 2000, Function and expression of multidrug resistance-associated protein family in human colon adenocarcinoma cells (Caco-2). Journal of Pharmacology and Experimental Therapeutics, 292, 265–270.
   PubMed Web of Science ®Google Scholar
• HUNTER, J., JEPSON, M. A., TSURUO, T., SIMMONS, N. L. and HIRST, B. H., 1993, Functional expression of P-glycoprotein in apical membranes of human intestinal Caco-2 cells. Journal of Biological Chemistry, 268, 14991–14997.
   PubMed Web of Science ®Google Scholar
• KIM, R. B., FROMM, M. F., WANDEL, C., LEAKE, B., WOOD, A. J. J., RODEN, D. M. and WILKINSON, G. R., 1998, The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors. Journal of Clinical Investigation, 101, 289–294.
   Google Scholar
• KUSUHARA, H., SUZUKI, H. and SUGIYAMA, Y., 1998, The role of P-glycoprotein and canalicular multispecific organic anion transporter in the hepatobiliary excretion of drugs. Journal of Pharmaceutical Sciences, 87, 1025–1040.
   PubMed Web of Science ®Google Scholar
• LEIER, I., JEDLITACHKY, G., Bucmio, U., COLE, S. P. C., DEELEY, R. G. and KEPPLER, D., 1994, The MRP gene encodes an ATP-dependent export pump for leukotriene C4 and structurally related conjugates. Journal of Biological Chemistry, 289, 27807–27810.
   Google Scholar
• MILLER, W. H., KEENAN, R. M., WILLETTE, R. N. and LARK, M. W., 2000, Identification and in vivo efficacy of small-molecule antagonists of integrin a,/33 (the vitronectin receptor). Drug Discovery Today, 5, 397–408.
   PubMed Web of Science ®Google Scholar
• MOTTINO, A. D., HOFFMAN, T., JENNES, L. and VORE, M., 2000, Expression and localization of multidrug resistant protein mrp2 in rat small intestine. Journal of Pharmacology and Experimental Therapeutics, 293, 717–723.
   PubMed Web of Science ®Google Scholar
• NEUHOFF, S., LANGGUTH, P, DRESSLER, C, ANDERSSON, T. B., REGARDH, C. G. and SPAHN-LANGGUTH, H., 2000, Affinities at the verapamil binding site of MDR1-encoded P-glycoprotein: drugs and analogs, stereoisomers and metabolites. International Journal of Clinical Pharmacology and Therapeutics, 38, 168–179.
   Google Scholar
• ORLOWSXI, S. and GARRIGOS, M., 1999, Multiple recognition of various amphiphilic molecules by the multidrug resistance P-glycoprotein: molecular mechanisms and pharmacological consequences coming from functional interactions between various drugs. Anticancer Research, 19, 3109–3123.
   PubMed Web of Science ®Google Scholar
• PRUEKSARITANONT, T., DELUNA, P., GORHAM, L. M., MA, B., COHN, D., PANG, J., XU, X., LEUNG, K. and LIN, J. H., 1998, In vitro and in vivo evaluations of intestinal barriers for the zwitterion L-767,679 and its carboxyl ester prodrug L-775,318: roles of efflux and metabolism. Drug Metabolism and Disposition, 26, 520–527.
   PubMed Web of Science ®Google Scholar
• SATO, W. and YAN O., 1997, Structure-activity relationship of newly synthesized quinoline derivatives for reversal of multidrug resistance in cancer. Journal of Medicinal Chemistry, 40, 2047–2052.
   PubMed Web of Science ®Google Scholar
• SCHINKEL, A. H., SMIT, J. J. M., VAN TELLINGEN, O., BEIJNEN, J. H., WARGENAAR, E., VAN DEEMTER, L., MOL, C. A. A. M., VAN DER VALK, M. A., ROBANUS-MAANDAG, E. C., TE RIELE, H. P. J, BERNS, A. J. M. and BORST, P., 1994, Disruption of the mouse mdrl a P-glycoprotein gene leads to deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell, 77, 491–502.
   Google Scholar
• SCHINKEL, A. H., WAGENAAR, E., VAN DEEMTER, L., MoL, C. A. A. M. and BORST, P., 1995, Absence of the mdrla P-glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A. Journal of Clinical Investigation, 97, 2517–2524.
   Google Scholar
• SZABO, D. and MOLNAR, J., 1998, The role of stereoselectivity of chemosensitizers in the reversal of multidrug resistance of mouse lymphoma cells. Anticancer Research, 18, 3039–3044.
   PubMed Web of Science ®Google Scholar
• TESTA, B., CRIVORI, P., REIST, M. and CARRUPT, P.-A., 2000, The influence of lipophilicity on the pharmacokinetic behavior of drugs: concepts and examples. Perspectives in Drug Discovery and Design, 19, 179–211.
   Google Scholar
• THIEBAUT, F., TSURUO, T., HAMADA, H., GOTTESMAN, M. M., PASTAN, I. and WILLINGHAM, M. C., 1987, Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proceedings of the National Academy of Sciences, USA, 84, 7735–7738.
   PubMed Web of Science ®Google Scholar
• WACHER, V. J., Wu, C. Y. and BENET, L. Z., 1995, Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P-glycoprotein: implications for drug delivery and activity in cancer chemotherapy. Molecular Carcinogenesis, 13, 129–134.
   PubMed Web of Science ®Google Scholar
• WATARI, N., WAKAMATSU, A. and KANENIWA, N., 1989, Comparison of disposition parameters of quinidine and quinine in the rats. Journal of Pharmacobio-Dynamics, 12, 608–615.
   PubMedGoogle Scholar
• VEZMAR, M., DEADY, L. W., TILLEY, L. and GEORGES, E., 1997, The quinoline-based drug N-{441-hydroxy-2(dibutylamino)ethyl]quinolin-8-y11-4-azadosalicylamide, photoaffinity labels the multidrug resistance protein (MRP) at a biologically relevant site. Biochemical and Biophysical Research Communications, 241, 104–111.
   PubMed Web of Science ®Google Scholar
• VEZMAR, M. and GEORGES, E., 2000, Reversal of MRP mediated doxorubicin resistance with quinoline based drugs. Biochemical Pharmacology, 59,1245–1252.
   PubMed Web of Science ®Google Scholar
• YAMAZAKI, M., NEWAY, W. E., OHE, T., CHEN, I. W., ROWE, J. F., HOCHMAN, J. H., CHIBA, M. and LIN, J. H., 2001, In vitro substrate identification studies for P-glycoprotein-mediated transport: species difference and predictability of in vivo results. Journal of Pharmacology and Experimental Therapeutics, 296, 723–735.
   PubMed Web of Science ®Google Scholar
• YOKOGAWA, K., TAKAHASHI, M., TAMAI, I., KONISHI, H., NOMURA, M., MORITANI, S., MIYAMOTO, K. and Tsuji, A., 1999, P-glycoprotein- dependent disposition kinetics of tacrolimus: studies in mdrla knockout mice. Pharmaceutical Research, 16, 1213–1218.
   PubMed Web of Science ®Google Scholar